Mesenchymal Stem Cell-derived Nanovesicles as a Credible Agent for Therapy of Pulmonary Hypertension.
Hu L, Wang J, Lin D, Shen Y, Huang H, Cao Y, Li Y, Li K, Yu Y, Yu Y, Chu C, Qin L, Wang X, Zhang H, Fulton D, Chen F.
Hu L, et al. Among authors: li y, li k.
Am J Respir Cell Mol Biol. 2022 Jul;67(1):61-75. doi: 10.1165/rcmb.2021-0415OC.
Am J Respir Cell Mol Biol. 2022.
PMID: 35507777